2. The drug behind Europe's most valuable com...

Are the u-turns on ID cards and business rates bad for the economy? Can the Northern Powerhouse Rail deliver what it’s promising? And why is Donald Trump strong-arming banks and oil companies in a way that looks more like old-fashioned state socialism than free-market capitalism? ...  Show more

Why is Britain’s innovation economy is the strongest in Europe? What can the government do to strengthen it further? And can the UK outperform even America and China? Steph and Robert sit down with 'professional optimist' Saul Klein, Co-Founder & Executive Chair of Phoenix Court ...  Show more

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

Episode 146: Neal and Toby list off all the exciting tidbits from Apple's big product event, including the iPhone 15 reveal. Next, how a covid-era government program is affecting poverty rates in America. Plus, quick relief from a cold may be gone as FDA declares a key ingredient ...  Show more

In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry.

How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 1 ...

On this week's episode of Networth and Chill, I'm joined by author and CEO of Rhoshan Pharmaceuticals, Hitha Palepu to talk drug prices and the pharmaceutical industry. Drug prices are a hot topic these days, and it seems like the cost of life saving medications like insulin and ...  Show more